Most Recent
Dr Reddy’s settles Millennium’s cancer drug patent suit
Intellectual Property September 18, 2018 1:54 pm By Miklos Bolza

Generic drug maker Dr Reddy’s Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Millennium wins injunction against Juno over generic cancer drug
Intellectual Property August 27, 2018 11:27 am By Christine Caulfield

US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
Intellectual Property August 23, 2018 5:41 pm By Miklos Bolza

An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Patent suits launched over breakthrough cancer drug
Intellectual Property August 15, 2018 10:25 pm By Miklos Bolza

Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.